Cargando…
Direct evidence of CRISPR-Cas9-mediated mitochondrial genome editing
Pathogenic mitochondrial DNA (mtDNA) mutations can cause a variety of human diseases. The recent development of genome-editing technologies to manipulate mtDNA, such as mitochondria-targeted DNA nucleases and base editors, offer a promising way for curing mitochondrial diseases caused by mtDNA mutat...
Autores principales: | Bi, Rui, Li, Yu, Xu, Min, Zheng, Quanzhen, Zhang, Deng-Feng, Li, Xiao, Ma, Guolan, Xiang, Bolin, Zhu, Xiaojia, Zhao, Hui, Huang, Xingxu, Zheng, Ping, Yao, Yong-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579715/ https://www.ncbi.nlm.nih.gov/pubmed/36275864 http://dx.doi.org/10.1016/j.xinn.2022.100329 |
Ejemplares similares
-
Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015) -
Easy quantification of template-directed CRISPR/Cas9 editing
por: Brinkman, Eva K, et al.
Publicado: (2018) -
FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
por: Cui, Zifeng, et al.
Publicado: (2022) -
Methods and applications of CRISPR/Cas system for genome editing in stem cells
por: Yang, Guang, et al.
Publicado: (2019) -
Genome editing in maize directed by CRISPR–Cas9 ribonucleoprotein complexes
por: Svitashev, Sergei, et al.
Publicado: (2016)